Biotechnology

Marizyme, Inc.

Marizyme, Inc. released FY2024 9 Months Earnings on March 5 (EST), with actual revenue of 32.86K USD and EPS of -0.1122 USD

Marizyme, Inc. released FY2024 Q3 earnings on March 5 (EST) with actual revenue of 0 USD and EPS of -0.0148 USD

Marizyme, Inc. released FY2024 Q2 earnings on August 14 (EST), actual revenue 0 USD, actual EPS -0.0501 USD

Marizyme, Inc. released FY2024 Semi-Annual Earnings on August 14 (EST), with actual revenue of 32.86K USD and EPS of -0.0973 USD

Marizyme, Inc. released FY2023 Q3 earnings on November 14 (EST), actual revenue 181.54K USD, actual EPS -0.5794 USD

Marizyme, Inc. released FY2023 9 Months Earnings on November 14 (EST), with actual revenue of 495.25K USD and EPS of -1.4765 USD

Marizyme, Inc. released FY2023 Semi-Annual Earnings on August 18 (EST) with actual revenue of 313.71K USD and EPS of -0.9199 USD

Marizyme, Inc. released FY2023 Q2 earnings on August 18 (EST), actual revenue 184.74K USD, actual EPS -0.8344 USD

Intelligent Bio Solutions

Anghami

UTime

ESH ACQUISITION CORP COM USD0.0001 CL A (S/R 13/06/2028)

Northann

FG MERGER II CORP COM USD0.0001 11/02/2030 (SUBS/RTS)

ESH Acquisition

INFLECTION POINT ACQUISITION CORP V COM USD0.0001 CL A (SUB/RIGHST)

RISING DRAGON ACQUISITION CORP COM USD0.0001 15/11/2028 (SUBS/RT)

Datavault AI

Adma Biologics

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel Pharma

OpGen

Vertex Pharma

Regeneron Pharma

Alnylam Pharma

Argenx

Beigene

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Marizyme, Inc.(MRZM.US)